HLA associations in end-stage renal disease due to membranous glomerulonephritis: HLA-DR3 associations with progressive renal injury. Southeastern Organ Procurement Foundation.

[1]  G. Hitman,et al.  Autoimmune renal disease and tumour necrosis factor beta gene polymorphism. , 1993, Clinical nephrology.

[2]  B. Freedman,et al.  The familial risk of end-stage renal disease in African Americans. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  M A Espeland,et al.  A race-controlled human leukocyte antigen frequency analysis in lupus nephritis. The South-Eastern Organ Procurement Foundation. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  J. Evans,et al.  Racial variation in human leukocyte antigen frequency in insulin-dependent diabetic nephropathy. The South-Eastern Organ Procurement Foundation. , 1993, Journal of the American Society of Nephrology : JASN.

[5]  M. Durkin,et al.  Biological functions of entactin. , 1993, Kidney international.

[6]  I. Dunham,et al.  Molecular mapping of the HLA class II region in HLA-DR3 associated idiopathic membranous nephropathy. , 1993, Kidney international. Supplement.

[7]  D. Boumpas,et al.  Membranous Nephropathy , 1992, Annals of Internal Medicine.

[8]  K. Arakawa,et al.  Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis. , 1992, Kidney international.

[9]  A. Cambon-Thomsen,et al.  Extensive genetic polymorphism in the human tumor necrosis factor region and relation to extended HLA haplotypes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Luke,et al.  Changing patterns of end-stage renal disease due to hypertension. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  M. Espeland,et al.  Racial differences in HLA antigen frequency and hypertensive renal failure. , 1991, American journal of hypertension.

[12]  K. Lemley,et al.  Anatomy of the renal interstitium. , 1991, Kidney international.

[13]  I. Caorsi,et al.  Idiopathic membranous nephropathy, associated with HLA-DRw3 and not related to monocyte-phagocyte system Fc receptor dysfunction, in father and son. , 1991, Nephron.

[14]  J. Petit,et al.  Immunogénétique des glomérulonéphrites extramembraneuses primitives. , 1990 .

[15]  H. Mcdevitt,et al.  Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Vaughan,et al.  A DQA1 allele is strongly associated with idiopathic membranous nephropathy. , 1989, Tissue antigens.

[17]  E. Neilson.  Pathogenesis and therapy of interstitial nephritis. , 1989, Kidney international.

[18]  Huang Cc.  Strong association of HLA-DR3 in Chinese patients with idiopathic membranous nephropathy. , 1989 .

[19]  C. Cardella,et al.  A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. , 1989, The New England journal of medicine.

[20]  P. Bacon,et al.  Natural course of penicillamine nephropathy: a long term study of 33 patients , 1988, British medical journal.

[21]  K. Arakawa,et al.  Association of class II antigens of HLA with primary glomerulopathies. , 1987, Nephron.

[22]  C. Ponticelli,et al.  A Randomized Trial of Methylprednisolone and Chlorambucil in Idiopathic Membranous Nephropathy , 1984 .

[23]  J. L. le Petit,et al.  Immunogenetics and immunopathology of human membranous glomerulonephritis. , 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[24]  J. L. le Petit,et al.  HLA-DR3 and idiopathic membranous nephritis (IMN) association. , 2008, Tissue antigens.

[25]  A. Green.  The epidemiologic approach to studies of association between HLA and disease. II. Estimation of absolute risks, etiologic and preventive fraction. , 1982, Tissue antigens.

[26]  P. Wernet,et al.  Strong association of idiopathic membranous nephropathy (IMN) with HLA-DR 3 and MT-2 without involvement of HLA-B 18 and no association to BfF1. , 2008, Tissue antigens.

[27]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[28]  E. J. Acheson,et al.  STRONG ASSOCIATION BETWEEN IDIOPATHIC MEMBRANOUS NEPHROPATHY AND HLA-DRW3. , 1979, The Lancet.

[29]  A. Hamlyn.  Letter: Blood-ethanol in liver disease. , 1975, Lancet.

[30]  O S Miettinen,et al.  Proportion of disease caused or prevented by a given exposure, trait or intervention. , 1974, American journal of epidemiology.

[31]  Nathan Mantel,et al.  Chi-square tests with one degree of freedom , 1963 .

[32]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.